Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 18 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 524394 | NSE: VIMTALABS

Vimta Labs Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 15, 2024, 7:28 pm

Market Cap 1,679 Cr.
Current Price 756
High / Low805/390
Stock P/E33.0
Book Value 152
Dividend Yield0.26 %
ROCE16.8 %
ROE12.9 %
Face Value 2.00
PEG Ratio2.59

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Vimta Labs Ltd

Competitors of Vimta Labs Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Choksi Laboratories Ltd 43.3 Cr. 62.294.0/38.334.9 33.00.00 %8.87 %5.12 % 10.0
Vimta Labs Ltd 1,679 Cr. 756805/39033.0 1520.26 %16.8 %12.9 % 2.00
Industry Average1,679.00 Cr409.1033.9592.500.13%12.84%9.01%6.00

All Competitor Stocks of Vimta Labs Ltd

Quarterly Result

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales61756774797976818272807880
Expenses44554651555455575857595557
Operating Profit17202023242521242415212424
OPM %27%26%31%31%30%32%27%29%29%21%26%30%29%
Other Income0-110111112101
Interest0001111001110
Depreciation5567788889988
Profit before tax1113151617181416168131616
Tax %26%26%25%27%27%26%27%23%25%25%25%24%26%
Net Profit81012121213101212691212
EPS in Rs3.674.305.235.375.445.914.505.545.252.674.275.325.25

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales109127116138154183213181209276315313311
Expenses8810199119127138155151156196222229228
Operating Profit21261719274558305380948483
OPM %19%20%15%14%18%25%27%17%25%29%30%27%27%
Other Income1311112310344
Interest3211255422322
Depreciation1591110101620212323313434
Profit before tax4187817263582855645252
Tax %4%25%24%23%36%36%28%17%25%26%26%25%
Net Profit4135611162572141473939
EPS in Rs1.905.992.292.914.797.4311.453.139.6218.5721.3717.5117.51
Dividend Payout %32%33%44%34%0%27%17%0%21%11%9%11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)225.00%-61.54%20.00%83.33%45.45%56.25%-72.00%200.00%95.24%14.63%-17.02%
Change in YoY Net Profit Growth (%)0.00%-286.54%81.54%63.33%-37.88%10.80%-128.25%272.00%-104.76%-80.60%-31.66%

Vimta Labs Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:8%
3 Years:14%
TTM:4%
Compounded Profit Growth
10 Years:11%
5 Years:9%
3 Years:22%
TTM:22%
Stock Price CAGR
10 Years:24%
5 Years:47%
3 Years:27%
1 Year:83%
Return on Equity
10 Years:12%
5 Years:14%
3 Years:17%
Last Year:13%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 6:35 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital4444444444444
Reserves108116118122132148167169190229276312334
Borrowings127426444026323019151912
Other Liabilities21222123424040394954656185
Total Liabilities145149146176222232237245273306360396435
Fixed Assets9390888888140135131128162168163175
CWIP020653042170125975
Investments0000000666666
Other Assets51575882809299105122138174168179
Total Assets145149146176222232237245273306360396435

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +161715-12433392437598759
Cash from Investing Activity +-4-8-8-16-39-24-16-20-32-38-57-75
Cash from Financing Activity +-11-8-91913-8-23-1-5-16-11-2
Net Cash Flow10-12-21131519-17

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow9.0019.0013.00-7.00-17.005.0032.00-2.0023.0061.0079.0065.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days87818210010111110011712810293101
Inventory Days165175158213183209199191140115187185
Days Payable1478766771841481151141398111961
Cash Conversion Cycle105169174236100172184194128136160224
Working Capital Days88841201266888871001169684102
ROCE %6%16%6%7%11%17%21%6%14%24%24%17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters37.46%37.46%37.46%37.46%37.26%37.25%37.23%37.00%36.98%36.92%36.89%36.89%
FIIs0.19%0.36%0.35%0.49%2.28%2.25%2.72%2.74%2.88%5.13%5.16%3.31%
DIIs1.91%1.96%2.01%2.04%2.13%2.14%2.14%1.50%1.49%1.50%1.49%0.00%
Public60.44%60.22%60.18%60.02%58.35%58.37%57.92%58.75%58.65%56.45%56.45%59.80%
No. of Shareholders19,19418,33218,10618,28318,91617,16217,43918,42919,95718,55019,05420,114

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund330,1520.114.99330,1522024-11-140%
Motilal Oswal S&P BSE Healthcare ETF780.040330,1522024-11-14-99.98%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)18.5121.7718.709.683.10
Diluted EPS (Rs.)18.2421.3518.329.683.10
Cash EPS (Rs.)33.9235.6529.2420.1212.56
Book Value[Excl.RevalReserv]/Share (Rs.)144.20127.33105.8387.9278.19
Book Value[Incl.RevalReserv]/Share (Rs.)144.20127.33105.8387.9278.19
Revenue From Operations / Share (Rs.)143.55143.78125.8695.2981.73
PBDIT / Share (Rs.)40.9644.4436.9724.3314.91
PBIT / Share (Rs.)25.5330.5726.4213.895.44
PBT / Share (Rs.)24.5729.3725.1912.913.74
Net Profit / Share (Rs.)18.5021.7718.699.683.10
NP After MI And SOA / Share (Rs.)18.5021.7718.699.683.10
PBDIT Margin (%)28.5230.9129.3725.5218.24
PBIT Margin (%)17.7821.2520.9814.576.65
PBT Margin (%)17.1120.4220.0113.544.57
Net Profit Margin (%)12.8815.1314.8510.163.78
NP After MI And SOA Margin (%)12.8815.1314.8510.163.78
Return on Networth / Equity (%)12.8217.0917.6611.013.95
Return on Capital Employeed (%)16.3622.1722.5113.926.39
Return On Assets (%)10.2513.2913.457.802.78
Long Term Debt / Equity (X)0.020.030.050.070.03
Total Debt / Equity (X)0.060.050.080.110.13
Asset Turnover Ratio (%)0.830.950.950.810.00
Current Ratio (X)2.912.862.602.051.67
Quick Ratio (X)2.462.462.241.781.37
Dividend Payout Ratio (NP) (%)10.799.1710.690.0064.60
Dividend Payout Ratio (CP) (%)5.885.606.830.0015.91
Earning Retention Ratio (%)89.2190.8389.310.0035.40
Cash Earning Retention Ratio (%)94.1294.4093.170.0084.09
Interest Coverage Ratio (X)42.7937.1954.5624.818.76
Interest Coverage Ratio (Post Tax) (X)20.3319.2129.4110.872.82
Enterprise Value (Cr.)979.08670.65704.61372.30147.42
EV / Net Operating Revenue (X)3.082.112.531.770.81
EV / EBITDA (X)10.786.828.626.924.47
MarketCap / Net Operating Revenue (X)3.102.192.501.690.72
Retention Ratios (%)89.2090.8289.300.0035.39
Price / BV (X)3.082.472.981.830.75
Price / Net Operating Revenue (X)3.102.192.501.690.72
EarningsYield0.040.060.050.060.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Vimta Labs Ltd as of November 18, 2024 is: 648.75

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 18, 2024, Vimta Labs Ltd is Overvalued by 14.19% compared to the current share price 756.00

Intrinsic Value of Vimta Labs Ltd as of November 18, 2024 is: 731.31

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 18, 2024, Vimta Labs Ltd is Overvalued by 3.27% compared to the current share price 756.00

Last 5 Year EPS CAGR: 12.73%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (186.23 cr) compared to borrowings (22.00 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (203.46 cr) and profit (28.77 cr) over the years.
  1. The stock has a low average ROCE of 14.08%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 96.58, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 165.17, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vimta Labs Ltd:
    1. Net Profit Margin: 12.88%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 16.36% (Industry Average ROCE: 12.84%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 12.82% (Industry Average ROE: 9.01%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 20.33
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.46
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 33 (Industry average Stock P/E: 33.95)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.06
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977. Currently company belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 275.98 Cr. and Equity Capital is Rs. 4.42 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Medical Research ServicesPlot Nos. 141/2 & 142, IDA Phase II, Hyderabad Telangana 500051shares@vimta.com
http://www.vimta.com
Management
NamePosition Held
Dr. Sivalinga Prasad VasireddiExecutive Chairman
Ms. Harita VasireddiManaging Director
Mr. Harriman VungalExecutive Director - Operations
Mr. Satya Sreenivas NeerukondaExecutive Director
Dr. Yadagiri R PendriIndependent Director
Ms. Prameela Rani YalamanchiliIndependent Director
Mr. Sanjay DaveIndependent Director
Mr. Purnachandra Rao GuttaIndependent Director

FAQ

What is the latest intrinsic value of Vimta Labs Ltd?

The latest intrinsic value of Vimta Labs Ltd as on 18 November 2024 is ₹648.75, which is 14.19% lower than the current market price of ₹756.00.

What is the Market Cap of Vimta Labs Ltd?

The Market Cap of Vimta Labs Ltd is 1,679 Cr..

What is the current Stock Price of Vimta Labs Ltd as on 18 November 2024?

The current stock price of Vimta Labs Ltd as on 18 November 2024 is ₹756.

What is the High / Low of Vimta Labs Ltd stocks in FY 2024?

In FY 2024, the High / Low of Vimta Labs Ltd stocks is 805/390.

What is the Stock P/E of Vimta Labs Ltd?

The Stock P/E of Vimta Labs Ltd is 33.0.

What is the Book Value of Vimta Labs Ltd?

The Book Value of Vimta Labs Ltd is 152.

What is the Dividend Yield of Vimta Labs Ltd?

The Dividend Yield of Vimta Labs Ltd is 0.26 %.

What is the ROCE of Vimta Labs Ltd?

The ROCE of Vimta Labs Ltd is 16.8 %.

What is the ROE of Vimta Labs Ltd?

The ROE of Vimta Labs Ltd is 12.9 %.

What is the Face Value of Vimta Labs Ltd?

The Face Value of Vimta Labs Ltd is 2.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Vimta Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE